Accord Synergy (ACCORD)

Score breakdown: P/E: 3/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Strong recent growth: sales up 47.91% and profit up 217.35%
• Low headline valuation: P/E of 11.93 and PEG of 0.09
• High promoter holding of 71.99% aligns owner interests with minority shareholders
• Piotroski F-Score of 6/9 suggests some improving financial fundamentals

Concerns

• ROCE is negative at -9.91%, indicating poor underlying capital efficiency
• Critical financial data missing: no book value, ROE, or debt-equity ratio
• Extreme price decline from ₹211 to ₹43.95 and tiny ₹10 crore market cap imply high risk and volatility
• Zero dividend yield means no income support while waiting for a turnaround

AI Analysis

When I look at Accord Synergy, I see the kind of small, obscure stock that Benjamin Graham would have examined with both interest and caution. The headline numbers look tempting: sales growth of 47.91%, profit growth of 217.35%, a trailing P/E of 11.93, and a PEG of 0.09. The entire company trades for only ₹10 crore. But value investing is not about buying low multiples; it is about buying a business that earns a good return on capital and can sustain those excess returns. Here the picture is murky. ROCE is -9.91%, which contradicts the idea of a healthy underlying business. I also have no book value, no ROE, and no debt-equity ratio, so I cannot apply Graham's margin-of-safety tests properly. The stock has fallen from ₹211 to ₹43.95, a decline of roughly 79%, and while that may create value, it also reflects a harsh market verdict. The latest quarter shows sales of ₹19 crore and net profit of ₹1 crore, so there is some earnings power, but at this market cap and with promoter holding at 71.99%, free float is tiny and volatility can be extreme. The Piotroski score of 6/9 is mildly encouraging, but not enough to overcome the lack of transparency. In the Buffett tradition, I prefer businesses with durable moats, stable returns, and understandable numbers. Accord Synergy does not yet meet that test. It may be a turnaround, or it may be a value trap. A cheap price without reliable economic fundamentals is not a margin of safety. I would watch it, not buy it yet.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer